Internal Medicine, Clinical Cardiatric Electrophysiology · New York, NY
NPI
1548214331
Since 2006
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1421 3rd Ave
New York, NY, 10028
Phone (212) 772-6384
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$115K
357 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey A Matos prescribed most often to Medicare patients was Metoprolol Succinate, with 89 prescriptions and refills. In total Jeffrey A Matos wrote 357 Medicare prescriptions that cost $115K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-03.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Metoprolol Succinate Generic | 89 | 238 | 27 | $2,192 |
| Eliquis Apixaban | 67 | 93 | Under 11 | $54K |
| Amiodarone Hcl Generic | 25 | 49 | Under 11 | $785 |
| Atorvastatin Calcium Generic | 23 | 53 | Under 11 | $323 |
| Norpace Cr Disopyramide Phosphate | 20 | 60 | Under 11 | $40K |
| Amlodipine Besylate Generic | 16 | 46 | Under 11 | $272 |
| Jardiance Empagliflozin | 13 | 13 | Under 11 | $7,974 |
Brand drugs: 112 claims; generic drugs: 245 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jeffrey A Matos were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.